Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study

Xiao-Xu Zhu,Jian-Hui Li,Peng Fang,Xiao-Fei Qu,Li-Jian Liang,Jia-Ming Lai,Xiao-Yu Yin

DOI: https://doi.org/10.1186/s12885-023-11152-2

IF: 4.638

2023-09-07

BMC Cancer

Abstract:Hypertension is a risk factor for cholangiocarcinoma (CCA). The effect of anti-hypertensive drugs on the prognosis of CCA is not clear.

oncology